Abstract

Objective: In this study, we aimed to determine the false-positive HIV test rate in pregnant women living in a low-endemic region for HIV infection and to develop appropriate strategies to prevent unnecessary antiretroviral prophylaxis.

Methods: A total of 115,217 women aged 18 years and older who applied to the Obstetrics and Gynecology Clinic of the Health Sciences University Gazi Yaşargil Training and Research Hospital between January 01, 2018, and December 31, 2022, and underwent ELISA HIV Ag/Ab testing were included in the retrospective study. HIV Ag/Ab tests were performed using the fourth-generation HIV Ag/Ab Combo chemiluminescence microparticle immunoassay method; positive results were confirmed in the reference laboratory.

Results: The HIV Ag/Ab ELISA test positivity rate was 0.18% (91/49,560) in pregnant women and 0.02% (14/65,657) in non-pregnant women. In confirmation tests and HIV-RNA tests, 2 (%0.004) pregnant and 3 (%0.005) non-pregnant women were found to be positive. False positive HIV tests were found at a rate of 0.18% (89/49,560) in pregnant women and 0.02% (11/65,657) in non-pregnant women; this difference was found to be statistically significant (p=0.016). It was observed that the mean HIV Ag/Ab S/Co titer was significantly higher in pregnant women with genuine HIV positivity.

Conclusion: The false positive rate in HIV Ag/Ab ELISA tests is higher in pregnant women than in non-pregnant women. In pregnant women with genuine HIV positivity, high HIV Ag/Ab S/Co titer values are striking. Due to the high false positive rates, it is recommended that HIV diagnosis in pregnant women be confirmed as soon as possible before starting antiretroviral treatment.

Show References

References

  1. HIV/AIDS Tanı Tedavi Rehberi [Internet]. Ankara: T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü; 2019. [erişim 3 Ekim 2024]. https://hsgm.saglik.gov.tr/depo/birimler/bulasici-hastaliklar-ve-erken-uyari-db/Dokumanlar/Rehberler/HIV-AIDS_Tani-Tedavi_Rehberi_2019.pdf
  2. Myburgh D, Rabie H, Slogrove AL, Edson C, Cotton MF, Dramowski A. Horizontal HIV transmission to children of HIV-uninfected mothers: A case series and review of the global literature. Int J Infect Dis. 2020;98:315-20. [CrossRef]
  3. Volmink J, Marais B. HIV: mother-to-child transmission. BMJ Clin Evid. 2008;2008:0909.
  4. Luzuriaga K. Mother-to-child transmission of HIV: a global perspective. Curr Infect Dis Rep. 2007;9(6):511-7. [CrossRef]
  5. Gökengin D, Oprea C, Uysal S, Begovac J. The growing HIV epidemic in Central Europe: a neglected issue? J Virus Erad. 2016;2(3):156-61. [CrossRef]
  6. Dayan S, Tekin A, Tekin R, et al. HBsAg, anti-HCV, anti-HIV 1/2 and syphilis seroprevalence in healthy volunteer blood donors in southeastern Anatolia. J Infect Dev Ctries. 2013;7(9):665-9. [CrossRef]
  7. Dayan S, Özekinci T, Bekçibaşi M, Deveci Ö. HBsAg, anti-HCV and anti-HIV seroprevalence among blood donors in Southeastern Anatolia, Turkey, 2011-2015. Infez Med. 2019;27(3):316-21.
  8. Yemisen M, Aydın OA, Gunduz A, et al. Epidemiological profile of naive HIV-1/AIDS patients in İstanbul: The largest case series from Turkey. Curr HIV Res. 2014;12(1):60-4. [CrossRef]
  9. Aslan FG, Altındiş M. Current Diagnostic Algorithm of HIV and Emerging Prevention Methods. Turk Mikrobiyol Cemiy Derg. 2017;47(2):47-60. [CrossRef]
  10. Doran TI, Parra E. False-positive and indeterminate human immunodeficiency virus test results in pregnant women. Arch Fam Med. 2000;9(9):924-9. [CrossRef]
  11. Wesolowski LG, Delaney KP, Lampe MA, Nesheim SR. False-positive human immunodeficiency virus enzyme immunoassay results in pregnant women. PLoS One. 2011;6(1):e16538. [CrossRef]
  12. T.C. Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü. HIV-AIDS Tanı ve Tedavi Rehberi. Ankara: Sağlık Bakanlığı; 2019 [erişim 3 Ekim 2024]. https://hsgm.saglik.gov.tr/depo/birimler/bulasici-hastaliklar-ve-erken-uyari-db/Dokumanlar/Rehberler/HIV-AIDS_Tani-Tedavi_Rehberi_2019.pdf
  13. Chacón L, Mateos ML, Holguín Á. Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting. J Clin Virol. 2017;92:11-3. [CrossRef]
  14. Wang L, Xiao Y, Tian XD, Ruan JX, Chen W, Yu Y. HIV infection in Xi’an, China: epidemic characterization, risk factors to false positives and potential utility of the sample-to-cutoff index to identify true positives using Architect HIV Ag/Ab combo. Antimicrob Resist Infect Control. 2019;8:9. [CrossRef]
  15. Adhikari EH, Macias D, Gaffney D, et al. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy. Am J Obstet Gynecol. 2018;219(4):408.e1-e9. [CrossRef]
  16. Sayan M, İnci A, Şanlı K. [Does anti-HIV positivity in pregnancy suggest the requirement of HIV prophylaxis for newborn?]. Klimik Derg. 2018;31(3):210-3. Turkish. [CrossRef]
  17. Güler E, Arıkan A, Abobakr M, Sayan M, Süer K, Şanlıdağ T. Positive anti-HIV ELISA results in pregnancy: Is it reliable? Infect Dis Obstet Gynecol. 2022;2022:1157793. [CrossRef]
Volume 38, Issue 3 Volume 38, Issue 2 Volume 38, Issue 1 Volume 37, Issue 4 Volume 37, Issue 3 Volume 37, Issue 2 Volume 37, Issue 1 Volume 36, Issue 4 Volume 36, Supplement 1 Volume 36, Issue 3 Volume 36, Issue 2 Volume 36, Issue 1 Volume 35, Issue 4 Volume 35, Issue 3 Volume 35, Issue 2 Volume 35, Issue 1 Volume 34, Issue 3 Volume 34, Issue 2 Volume 34, Issue 1 Volume 33, Issue 3 Volume 33, Issue 2 Volume 33, Issue 1 Volume 32, Issue 3 Volume 32, Supplement 1 Volume 32, Supplement 2 Volume 32, Issue 2 Volume 32, Issue 1 Volume 31, Issue 3 Volume 31, Issue 2 Volume 31, Supplement 1 Volume 31, Issue 1 Volume 30, Issue 3 Volume 30, Issue 2 Volume 30, Supplement 1 Volume 30, Issue 1 Volume 29, Issue 3 Volume 29, Issue 2 Volume 29, Issue 1 Volume 28, Supplement 1 Volume 28, Issue 3 Volume 28, Issue 2 Volume 28, Issue 1 Volume 27, Supplement 1 Volume 27, Issue 3 Volume 27, Issue 2 Volume 27, Issue 1 Volume 26, Issue 3 Volume 26, Supplement 1 Volume 26, Issue 2 Volume 26, Issue 1 Volume 25, Issue 3 Volume 25, Issue 2 Volume 25, Issue 1 Volume 24, Issue 3 Volume 24, Issue 2 Volume 24, Issue 1 Volume 23, Issue 3 Volume 23, Issue 2 Volume 23, Issue 1 Volume 22, Issue 3 Volume 22, Issue 2 Volume 22, Issue 1 Volume 21, Issue 3 Volume 21, Supplement 2 Volume 21, Supplement 1 Volume 21, Issue 2 Volume 21, Issue 1 Volume 20, Issue 3 Volume 20, Supplement 2 Volume 20, Issue 2 Volume 20, Issue 1 Volume 20, Supplement 1 Volume 19, Issue 3 Volume 19, Issue 2 Volume 19, Issue 1 Volume 18, Issue 3 Volume 18, Supplement 1 Volume 18, Issue 2 Volume 18, Issue 1 Volume 17, Issue 3 Volume 17, Issue 2 Volume 17, Issue 1 Volume 16, Issue 3 Volume 16, Issue 2 Volume 16, Issue 1 Volume 1, Supplement 1 Volume 15, Issue 3 Volume 15, Issue 2 Volume 15, Issue 1 Volume 14, Issue 3 Volume 14, Issue 2 Volume 14, Issue 1 Volume 13, Issue 3 Volume 13, Issue 2 Volume 13, Supplement 1 Volume 13, Issue 1 Volume 12, Issue 3 Volume 12, Issue 2 Volume 12, Issue 1 Volume 11, Issue 3 Volume 11, Issue 2 Volume 11, Supplement 1 Volume 11, Issue 1 Volume 10, Issue 3 Volume 10, Issue 2 Volume 10, Issue 1 Volume 9, Issue 3 Volume 9, Issue 2 Volume 9, Issue 1 Volume 8, Issue 3 Volume 8, Issue 2 Volume 8, Issue 1 Volume 6, Issue 3 Volume 7, Issue 1 Volume 7, Issue 2 Volume 7, Issue 3 Volume 4, Issue 3 Volume 5, Issue 1 Volume 5, Issue 2 Volume 5, Issue 3 Volume 6, Issue 1 Volume 6, Issue 2 Volume 3, Issue 1 Volume 3, Issue 2 Volume 3, Issue 3 Volume 4, Issue 1 Volume 4, Issue 2 Volume 1, Issue 2 Volume 2, Issue 1 Volume 2, Issue 2 Volume 2, Issue 3 Volume 1, Issue 1